Health care industry
Novo Nordisk’s diabetes pill slashes risk of cardiovascular complications by 14% after four years
Novo Nordisk on Saturday said its diabetes pill Rybelsus showed cardiovascular benefits in a late-stage trial, paving the way for it to become a new treatment option for people living with diabetes and heart disease. The pill lowered the risk of cardiovascular-related death, heart attack and stroke by 14% compared to a placebo after four […]
Read More
New blood pressure drug helps people with uncontrolled hypertension in trial
A new type of medication may help lower blood pressure in people with uncontrolled hypertension, researchers reported Saturday at the annual meeting of American College of Cardiology in Chicago. In a pivotal Phase 2b clinical trial, patients who took the experimental medication lorundrostat along with two or three currently available hypertension drugs saw a decrease in systolic […]
Read More
Top FDA vaccine official Peter Marks resigns in opposition to RFK Jr.
Dr. Peter Marks, Director of the Center for Biologics Evaluation and Research within the Food and Drug Administration answers a question during a Senate Health, Education, Labor and Pensions Committee hearing to discuss the on-going federal response to COVID-19, at the U.S. Capitol in Washington, D.C., May 11, 2021. Greg Nash | Pool | Reuters […]
Read More
We’re buying more shares of 2 stocks as the broader market sinks further
We’re making our first trades of the week. We are buying 25 shares of Danaher at roughly $207 each. Following Friday’s trade, Jim Cramer’s Charitable Trust will own 550 shares of DHR, increasing its weighting to 3.5% from 3.35%. We are buying 10 shares of Home Depot at roughly $358. Following the trade, the Trust […]
Read More
U.S. health department plans to slash 10,000 jobs as RFK Jr. upends agencies
Robert F. Kennedy Jr., US secretary of Health and Human Services (HHS), during a cabinet meeting at the White House in Washington, DC, US, on Monday, March 24, 2025. Samuel Corum | Bloomberg | Getty Images Health and Human Services Secretary Robert F. Kennedy Jr. plans to slash 10,000 full-time employees across different departments, as […]
Read More
Former Citi CEO Sandy Weill launches new cancer research hub focused on immunotherapy
Sandy Weill, former CEO of Citigroup, in 2014. Adam Jeffery | CNBC Former Citigroup CEO Sandy Weill announced Thursday morning a $50 million gift through the Weill Family Foundation to establish the Weill Cancer Hub East, a partnership aimed at using research on nutrition and metabolism to develop cancer treatments. The partnership brings together four […]
Read More
How one of Japan’s largest insurers is pivoting to serve an aging population
Sompo Holdings, a leading global insurance provider, is undergoing a significant transformation under. CNBC’s Christine Tan sat down with Group CEO Mikio Okumura in this episode of “Managing Asia.” Sompo Holdings, a leading global insurance provider, is undergoing a significant transformation under Group CEO Mikio Okumura. The company, with operations in 28 countries, has restructured […]
Read More
23andMe co-founder lashes out at CEO Wojcicki after bankruptcy filing, says board lacked oversight
A view of 23andMe headquarters in Sunnyvale, California, United States on March 25, 2025. Tayfun Coskun | Anadolu | Getty Images 23andMe co-founder Linda Avey took to social media on Wednesday to express frustration about the fate of the once-thriving genetics testing company that spiraled into Chapter 11 bankruptcy protection this week. Avey helped launch […]
Read More
Amazon Pharmacy medical chief Gupta is latest health exec to leave company
Vin Gupta, Chief Medical Officer at Amazon Pharmacy, speaks during Amazon’s “Delivering the Future” event at the company’s BFI1 Fulfillment Center, Robotics Research and Development Hub in Sumner, Washington on October 18, 2023. Jason Redmond | Afp | Getty Images Amazon has lost the chief medical officer of its pharmacy division after five years at […]
Read More
Life science stocks are under pressure due to possible NIH funding cuts. What lies ahead for the sector
A recent move by the Trump administration to substantially lower funding from the National Institutes of Health for research institutions around the country has investors fearing meaningful losses for life science tools companies. The NIH announced in early February that it would cap research funding at 15% for “indirect costs” – those that aren’t directly […]
Read More